O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+14.59%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.71B
AUM Growth
+$8.71B
(-8.1%)
Cap. Flow
-$1.43B
Cap. Flow
% of AUM
-16.47%
Top 10 Holdings %
Top 10 Hldgs %
33.55%
Holding
149
New
15
Increased
27
Reduced
39
Closed
13
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$130M |
| 2 |
Edwards Lifesciences
EW
|
$104M |
| 3 |
Merck
MRK
|
$99.3M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$85.5M |
| 5 |
Exelixis
EXEL
|
$79.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$211M |
| 2 |
Bristol-Myers Squibb
BMY
|
$155M |
| 3 |
AbbVie
ABBV
|
$148M |
| 4 |
Boston Scientific
BSX
|
$141M |
| 5 |
RLYP
RELYPSA INC COM
RLYP
|
$137M |
Sector Composition
| 1 | Healthcare | 93.45% |
| 2 | Financials | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
51
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $53.8M | 0.61% |
1,166,200
-981,900
| -46% | -$45.3M |
|
52
Intellia Therapeutics
NTLA
$1.26B
| $45.3M | 0.52% |
2,662,180
| – | – |
|
|
LOXO
53
DELISTED
Loxo Oncology, Inc
LOXO
| $45.2M | 0.52% |
1,728,000
-447,857
| -21% | -$11.7M |
|
54
Tenet Healthcare
THC
$16.5B
| $45.2M | 0.51% |
1,993,000
+1,077,700
| +118% | +$24.4M |
|
55
Cooper Companies
COO
$13.3B
| $44.8M | 0.51% |
250,100
-426,200
| -63% | -$76.4M |
|
56
Ascendis Pharma
ASND
$12.1B
| $44M | 0.5% |
2,191,000
| – | – |
|
|
DMTX
57
DELISTED
Dimension Therapeutics, Inc
DMTX
| $43.1M | 0.49% |
5,397,698
| – | – |
|
58
Cigna
CI
$80.2B
| $42.4M | 0.48% |
325,700
-3,900
| -1% | -$508K |
|
|
VRAY
59
DELISTED
ViewRay, Inc.
VRAY
| $41.3M | 0.47% |
9,127,990
+1,138,074
| +14% | +$5.14M |
|
|
MGLN
60
DELISTED
Magellan Health Services, Inc.
MGLN
| $37.6M | 0.43% |
699,700
-390,900
| -36% | -$21M |
|
|
OTIC
61
DELISTED
Otonomy, Inc.
OTIC
| $33.7M | 0.38% |
1,850,094
| – | – |
|
|
SGYP
62
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $32.9M | 0.38% |
5,976,648
| – | – |
|
|
AERI
63
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $30.1M | 0.34% |
+797,100
| New | +$30.1M |
|
64
Jazz Pharmaceuticals
JAZZ
$7.99B
| $30M | 0.34% |
246,900
+156,900
| +174% | +$19.1M |
|
65
Galapagos
GLPG
$2.06B
| $29.6M | 0.34% |
457,900
+105,200
| +30% | +$6.8M |
|
|
LUMO
66
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $29.1M | 0.33% |
1,938,300
+356,794
| +23% | +$5.36M |
|
67
Iovance Biotherapeutics
IOVA
$800M
| $27.8M | 0.32% |
3,382,900
| – | – |
|
68
Cartesian Therapeutics
RNAC
$267M
| $26.3M | 0.3% |
1,842,797
| – | – |
|
69
Stryker
SYK
$149B
| $24.7M | 0.28% |
212,000
| – | – |
|
70
Exact Sciences
EXAS
$9.33B
| $20.5M | 0.23% |
1,101,600
-1,029,600
| -48% | -$19.1M |
|
71
eHealth
EHTH
$126M
| $20.3M | 0.23% |
1,815,000
+515,000
| +40% | +$5.77M |
|
|
CYNA
72
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $20.1M | 0.23% |
499,999
-640,326
| -56% | -$25.8M |
|
73
Abbott
ABT
$230B
| $18.6M | 0.21% |
440,500
+203,500
| +86% | +$8.61M |
|
74
Xencor
XNCR
$594M
| $18.2M | 0.21% |
744,522
-126,300
| -15% | -$3.09M |
|
75
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $18M | 0.2% |
+671,600
| New | +$18M |
|